Search alternatives:
larger decrease » marked decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
larger decrease » marked decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
4481
Office characteristics and RW adoption.
Published 2025“…The number of workers with LTSA-MD nominally decreased from fiscal 2019 to fiscal year 2020, with no significant difference. …”
-
4482
Loxoprofen or SB225002 administration attenuated inflammatory pain in complete Freund’s adjuvant (CFA)-injected mice exposed to sound stress.
Published 2025“…<b>(A)</b> Loxoprofen administration (500 mg/kg) significantly decreased the response times to filament in CFA + saline group 60 min after administration (***<i>P</i> < 0.001), and in CFA + stress + saline group (30 and 60 min after administration, **<i>P</i> < 0.01). …”
-
4483
-
4484
-
4485
Table 1_LpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity.docx
Published 2025“…We previously developed a live attenuated auxotrophic vaccine candidate, PAO1 ΔmurI, which conferred protection in murine infection models but exhibited significant reactogenicity when administered intranasally. …”
-
4486
PRISMA flowchart of the included studies.
Published 2025“…On the other hand, patients in the immunotherapy group had significantly decreased HbA1c levels (MD = -0.63; 95% CI: [-1.18, -0.07]; p = 0.03), indicating that immunotherapy had a positive impact on glycemic management. …”
-
4487
Characteristics of Included Studies.
Published 2025“…On the other hand, patients in the immunotherapy group had significantly decreased HbA1c levels (MD = -0.63; 95% CI: [-1.18, -0.07]; p = 0.03), indicating that immunotherapy had a positive impact on glycemic management. …”
-
4488
Assessment of the relationship between adiposity, Sirtuin 1, and miR-30a-5p in a mixed-ancestry population in Bellville South, Cape Town.
Published 2025“…</p><p dir="ltr"><b>Study Results</b>: A total of 150 females and 150 males were selected for this study with an average age of 50 years. miR-30a-5p expression was significantly higher in overweight and obese participants compared to normal-weight individuals. …”
-
4489
Table 1_Genetic variants in the vitamin D pathway genes are predictors of the risk of diabetic kidney disease in Central Asian Kazakhstani cohort with type 2 diabetes.docx
Published 2025“…</p>Results<p>The CYP27A1 rs17470271 T/T genotype was significantly associated with a reduced risk of DKD under the recessive model (AOR = 0.32, 95% CI: 0.11–0.93). …”
-
4490
Image 2_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.tif
Published 2025“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”
-
4491
Image 3_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.tif
Published 2025“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”
-
4492
Table 2_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.docx
Published 2025“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”
-
4493
Table 10_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.xlsx
Published 2025“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”
-
4494
Table 3_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.xlsx
Published 2025“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”
-
4495
Table 7_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.doc
Published 2025“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”
-
4496
Image 8_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.tif
Published 2025“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”
-
4497
Table 6_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.doc
Published 2025“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”
-
4498
Table 8_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.xlsx
Published 2025“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”
-
4499
Image 5_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.tif
Published 2025“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”
-
4500
Image 14_Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.tif
Published 2025“…</p>Results<p>The findings indicated a significant decrease in C1QTNF1-AS1 expression levels in OS cells compared to normal osteoblasts. …”